Spatial and temporal expression of surfactant proteins in hyperoxia-induced neonatal rat lung injury

BMC Pulmonary Medicine

Volumn 6, Issue , 2006, Pages

  ter Horst, Simone A J ^a   Fijlstra, Margot ^a   Sengupta, Sujata ^a   Walther, Frans J ^a,b   Wagenaar, Gerry T M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARA CELL PROTEIN; MESSENGER RNA; OXYGEN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D;

AMBIENT AIR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELLULAR DISTRIBUTION; CLARA CELL; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GENE EXPRESSION; HYPEROXIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LOWER RESPIRATORY TRACT; LUNG ALVEOLUS CELL TYPE 2; LUNG DYSPLASIA; LUNG INJURY; LUNG PARENCHYMA; MALE; NEWBORN; NEWBORN PERIOD; NONHUMAN; OXIDATIVE STRESS; PERINATAL DEVELOPMENT; PREMATURITY; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANIMALS, NEWBORN; BRONCHI; HYPEROXIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG DISEASES; MALE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TISSUE DISTRIBUTION; UTEROGLOBIN;

EID: 33745080376     PISSN: 14712466     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-6-8     Document Type: Article

References (35)

1. Jobe AH: The new BPD: an arrest of lung development. Pediatr Res 1999, 46:641-643.
2. Bancalari E. Gonzalez A: Clinical course and lung function abnormalities during development of neonatal chronic lung disease. In Chronic lung disease in early infancy Edited by: Bland RD, Coalson JJ. New York: Marcel Dekker; 2000.
3. Jobe AH, Bancalari E: Bronchopulmonary Dysplasia. Am J Respir Crit Care Med 2001, 163:1723-1729.
4. Coalson JJ: Experimental models of bronchopulmonary dysplasia. Biol Neonate 1997, 71:35-38.
5. Warner BB, Stuart LA, Papes RA, Wispé JR: Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 1998, 275:L110-L117.
6. Roberts RJ, Weesner KM, Bucher JR: Oxygen-induced alterations in lung vascular development in the newborn rat. Pediatr Res 1983, 17:368-375.
7. Han RNN, Buch S, Tseu I, Youngh J, Christie NA, Frndova H, Lye SJ, Post M, Tanswell AK: Changes in structure, mechanics and insulin-like growth factor-related gene expression in the lungs of newborn rats exposed to air or 60% oxygen. Pediatr Res 1996, 39:921-929.
8. Chen Y, Martinez MA, Frank L: Prenatal dexamethasone administration to premature rats exposed to prolonged hyperoxia: a new rat model of pulmonary fibrosis (bronchopulmonary dysplasia). J Pediatr 1997, 130:409-416.
9. Wagenaar GTM, ter Horst SA, Van Gastelen MA, Leijer LM, Mauad T, van der Velden PA, de Heer E, Hiemstra PS, Poorthuis BJHM, Walther FJ: Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress. Free Radic Bio Med 2004, 36:782-801.
10. Clark C, Clark LS: The genetics of neonatal respiratory disease. Semin Fetal Neonatal Med 2005, 10:271-282.
11. Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll Bj, Verter J, Temprosa M, Wright LL, Ehrenkranz RA, Fanaroff AA, Stark A, Carlo W, Tyson JE, Donovan EF, Shankaran S, Stevenson DK: Very low birth weight outcomes ofthe National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 2001, 107:E1.
12. Engstrom PC, Holm BA, Matalon S: Surfactant replacement attenuates the increase in alveolar permeability in hyperoxia. J App Physio 1989, 67:688-693.
13. Matalon S, Holm BA, Notter RH: Mitigation of pulmonary hyperoxic injury by administration of exogenous surfactant. J Appl Physiol 1987, 62:756-761.
14. Holm BA, Notter RH, Siegle J, Matalon S: Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia. J Appl Physiol 1985, 59:1402-1409.
15. Novotny WE, Hudak BB, Matalon S, Holm BA: Hyperoxic lung injury reduces exogenous surfactant clearance in vivo. Am J Respir Crit Care Med 1995, 151:1843-1847.
16. Nogee LM, Wispe JR, Clark JC, Weaver TE, Whitsett JA: Increased expression of pulmonary surfactant proteins in oxygen-exposed rats. Am J Respir Cell Mol Biol 1991, 4:102-107.
17. Nogee LM, Wispe JR, Clark JC, Whitsett JA: Increased synthesis and mRNA expression of surfactant protein A in oxygen-exposed rats. Am J Respir Cell Mol Biol 1989, 1:119-125.
18. Horowitz S, Shapiro DL, Finkelstein JN, Notter RH, Johnston CJ, Quible DJ: Changes in gene expression in hyperoxia-induced neonatal lung injury. Am J Physiol 1990, 258:L107-L111.
19. Horowitz S, Watkins RH, Auten RL Jr, Mercier CE, Cheng ERY: Differential accumulation of surfactant protein A, B and C mRNAs in two epithelial cell types of hyperoxic lung. Am J Respir Cell Mol Biol 1991, 5:511-515.
20. D'Angio CT. Finkelstein JN, Lomonaco MB, Paxhia A, Wright SA, Baggs RB, Notter RH, Ryan RM: Changes in surfactant protein gene expression in a neonatal rabbit model of hyperoxia-induced fibrosis. Am J Physiol 1997, 272:L720-L730.
21. White CW, Greene KE, Allen CB, Shannon JM: Elevated expression of surfactant proteins in newborn rats during adaptation to hyperoxia. Am J Respir Cell Mol Biol 2001, 25:51-59.
22. van Tuyl M, Blommaart PE, de Boer PAJ, Wert SE, Ruijter JM, Islam S, Schnitzer J, Ellison AR, Tibboel D, Moorman AFM, Lamers WH: Prenatal exposure to thyroid hormone is necessary for normal postnatal development of murine hearts and lungs. Dev Biol 2004, 272:104-117.
23. ter Horst SAJ, Wagenaar GTM, de Boer E, van Gastelen MA, Meijers JCM, Biemond BJ, Poorthuis BJHM, Walther FJ: Pentoxifylline reduces fibrin deposition and prolongs survival in neonatal hyperoxic lung injury. J Appl Physiol 2004, 97:2014-2019.
24. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:E45-E45.
25. Wilkinson DG: In situ Hybridization. A practical approach. Edited by: Rickwood D. Hames BD. Oxford: IRL Press at Oxford university press; 1992.
26. Lacaze-Masmonteil T, Fraslon C, Bourbon J, Raymondjean M. Kahn A: Characterization of the rat surfactant protein A promoter. Eur J Biochem 1992, 206:613-623.
27. Shimizu H, Fisher JH, Papst P, Benson B, Lau K. Mason RJ, Voelker DR: Primary structure of rat pulmonary surfactant protein D: cDNA and deduced amino acid sequence. J Biol Chem 1992, 267:1853-1857
28. Plopper CG: Lung growth and development Edited by: McDonald JA. New York: Marcel Dekker; 1997:181-202.
29. Veness-Meehan KA, Cheng ERY, Mercier CE, Blixt SL, Johnston CJ, Watkins RH, Horowitz S: Cell-specific alterations in expression of hyperoxia-induced mRNAs of lung. Am J Respir Cell Mol Biol 1991, 5:516-521.
30. 2 exposure effects on surfactant protein and mRNA in rat alveolar and bronchiolar epithelium. Am J Physiol 1999, 276:L999-L1009.
31. Awasthi S, Coalson JJ, Crouch E, Yang F, King RJ: Surfactant proteins A and D in premature baboons with chronic lung injury (Bronchopulmonary dysplasia). Evidence for an inhibition of secretion. Am J Crit Care Med 1999, 160:942-949.
32. Woods E, Ohashi T, Polk D, Ikegami M, Ueda T, Jobe AH: Surfactant treatment and ventilation effects on surfactant SP-A, SP-B,and SP-C mRNA levels in preterm lamb lungs. Am J Physiol 1995, 269:L209-L214.
33. Beresford MW, Shaw NJ: Bronchoalveolar lavage surfactant protein A, B, and D concentrations in preterm infants ventilated for respiratory distress syndrome receiving natural and synthetic surfactants. Pediatr Res 2003, 53:663-670.
34. Merrill JD, Ballard RA, Cnaan A, Hibbs AM, Godinez RI, Godinez MH. Truog WE, Ballard PL: Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediotr Res 2004, 56:918-926.
35. Hallman M, Merritt TA, Akino T, Bry K: Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid: Correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants. Am Rev Respir Dis 1991, 144:1376-84.